Tci Gene (ROCO:6879) Pre-Tax Income : NT$8.8 Mil (TTM As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Tci Gene Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Tci Gene's pretax income for the six months ended in Dec. 2023 was NT$5.4 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was NT$8.8 Mil. Tci Gene's pretax margin was 2.91%.

During the past 5 years, Tci Gene's highest Pretax Margin was 30.38%. The lowest was 2.63%. And the median was 24.86%.

Tci Gene Pre-Tax Income Historical Data

The historical data trend for Tci Gene's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tci Gene Pre-Tax Income Chart

Tci Gene Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Pre-Tax Income

57.37

47.96

116.44

90.13

8.78

Tci Gene Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Pre-Tax Income	Get a 7-Day Free Trial				81.74	80.81	9.32	3.42	5.36

Competitive Comparison of Tci Gene's Pre-Tax Income

For the Biotechnology subindustry, Tci Gene's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tci Gene's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tci Gene's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Tci Gene's Pre-Tax Income falls into.

Tci Gene Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Tci Gene's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	6.02	+	0	+	-1.184	+	9.673	+	-5.734
	=	8.8

Tci Gene's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	4.281	+	0	+	-0.565	+	4.892	+	-3.25
	=	5.4

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$8.8 Mil.

Tci Gene (ROCO:6879) Pre-Tax Income Explanation

Tci Gene's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	5.358	/	183.992
	=	2.91%

During the past 5 years, Tci Gene's highest Pretax Margin was 30.38%. The lowest was 2.63%. And the median was 24.86%.

Tci Gene Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Tci Gene's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Tci Gene (ROCO:6879) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tci Gene Inc (ROCO:6879) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 185-1, Gangqian Rd, 10th FLoor, Neihu District, Taipei, TWN

Website

https://www.genext.me

Tci Gene Inc provides precision preventive medicines in Taiwan. It is the first to introduce the concept of precision preventive medicine with Predict prediction, Prevent prevention, and Personal Treatment personalized health management measures.

Tci Gene (ROCO:6879) Headlines

No Headlines